相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Soluble stroma-related biomarkers of pancreatic cancer
Andrea Resovi et al.
EMBO MOLECULAR MEDICINE (2018)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal
Maarten F. Bijlsma et al.
CANCER AND METASTASIS REVIEWS (2015)
SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial
Manuel Hidalgo et al.
CLINICAL CANCER RESEARCH (2015)
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
David Goldstein et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract
Helene Damhofer et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
Richard A. Moffitt et al.
NATURE GENETICS (2015)
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
David Goldstein et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Blocking Hedgehog release from pancreatic cancer cells increases paracrine signaling potency
Helene Damhofer et al.
JOURNAL OF CELL SCIENCE (2015)
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
Berna C. Oezdemir et al.
CANCER CELL (2014)
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Andrew D. Rhim et al.
CANCER CELL (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice
Albrecht Neesse et al.
GUT (2014)
Stromal response to Hedgehog signaling restrains pancreatic cancer progression
John J. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Stromal disrupting effects of nab-paclitaxel in pancreatic cancer
R. Alvarez et al.
BRITISH JOURNAL OF CANCER (2013)
Integration of Metabolomics and Transcriptomics Revealed a Fatty Acid Network Exerting Growth Inhibitory Effects in Human Pancreatic Cancer
Geng Zhang et al.
CLINICAL CANCER RESEARCH (2013)
Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes
Raghu Kadaba et al.
JOURNAL OF PATHOLOGY (2013)
Assessment of the stromal contribution to Sonic Hedgehog-dependent pancreatic adenocarcinoma
Helene Damhofer et al.
MOLECULAR ONCOLOGY (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis
Christine M. Ardito et al.
CANCER CELL (2012)
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma
Pedro A. Perez-Mancera et al.
NATURE (2012)
Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
Daniel D. Von Hoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A. Collisson et al.
NATURE MEDICINE (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Pancreatic Cancer
Manuel Hidalgo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients
Neil Desai et al.
TRANSLATIONAL ONCOLOGY (2009)
Cellular roles of ADAM12 in health and disease
Marie Kveiborg et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling
Christian Pilarsky et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx
Keisuke Horiuchi et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Molecular profiling of ADAM12 in human bladder cancer
Camilla Frohlich et al.
CLINICAL CANCER RESEARCH (2006)
ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression
L. Peduto et al.
ONCOGENE (2006)
Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC)
N Rocks et al.
BRITISH JOURNAL OF CANCER (2006)
The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-β
M Tojo et al.
CANCER SCIENCE (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Differential and synergistic effects of platelet-derived growth factor-BB and transforming growth factor-β1 on activated pancreatic stellate cells
C Kordes et al.
PANCREAS (2005)
Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells
MG Bachem et al.
GASTROENTEROLOGY (2005)
ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage
R Roy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The molecular basis of pancreatic fibrosis - Common stromal gene expression in chronic pancreatitis and pancreatic adenocarcinoma
CE Binkley et al.
PANCREAS (2004)
ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor
T Kodama et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
ADAM12 in human liver cancers:: TGF-β-regulated expression in stellate cells is associated with matrix remodeling
H Le Pabic et al.
HEPATOLOGY (2003)
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
M Asakura et al.
NATURE MEDICINE (2002)
分享论文
